Trials / Recruiting
RecruitingNCT05997186
Reinnervated PAP Flap for Oral Cavity and Oropharyngeal Defect Reconstruction
Sensory Recovery and Functional Outcome After Reinnervated Profunda Artery Perforator Flap for Oral Cavity and Oropharyngeal Defect Reconstruction - Prospective Pilot Study
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- University Hospital, Basel, Switzerland · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to investigate sensory recovery and functional outcomes following oral cavity and oropharyngeal defect reconstruction with reinnervated PAP (profunda artery perforator) flaps.
Detailed description
Tumor resections involving the oral cavity or oropharynx cause significant functional deficits in swallowing and speech and subsequently impair the patients' quality of life. The anterolateral thigh (ALT) flap is widely regarded as a workhorse flap to reconstruct such defects. Previous studies assessing recovery of reinnervated ALT flaps reported superior sensory recovery, improved swallow function, and improved overall patient satisfaction in patients with reinnervated flaps compared with patients who received ALT flap reconstruction without sensory reinnervation. Recently, the profunda artery perforator (PAP) flap has been proposed as an alternative donor site in malnourished patients with thin lateral thigh thickness. However, reinnervation of PAP flaps has not been described. The study assesses sensory recovery after defect reconstruction with the reinnervated profunda artery perforator flap using already approved, non-invasive testing (Semmes-Weinstein monofilament testing, two-point discrimination, temperature, pain perception)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Surgical reconstruction | Surgical reconstruction with a free reinnervated profunda artery perforator flap |
Timeline
- Start date
- 2023-09-01
- Primary completion
- 2027-05-01
- Completion
- 2027-05-01
- First posted
- 2023-08-18
- Last updated
- 2025-02-18
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT05997186. Inclusion in this directory is not an endorsement.